ENERGY EXPENDITURE MEASURES FOR ACTIVITIES OF DAILY LIVING IN YOUNG ADULTS: A PILOT STUDY.

2004 ◽  
Vol 18 (4) ◽  
pp. 28
Author(s):  
Jacqueline S. Drouin ◽  
Jonathan Dewick ◽  
Kevin Bridges ◽  
Craig A. Fox ◽  
Rebecca White
Keyword(s):  
Young Adults ◽  
Pilot Study ◽  
Energy Expenditure ◽  
Activities Of Daily Living ◽  
Daily Living

ENERGY EXPENDITURE MEASURES FOR ACTIVITIES OF DAILY LIVING IN YOUNG ADULTS: A PILOT STUDY.

2007 ◽  
Vol 18 (4) ◽  
pp. 28
Author(s):  
Jacqueline S. Drouin ◽  
Jonathan Dewick ◽  
Kevin Bridges ◽  
Craig A. Fox ◽  
Rebecca White
Keyword(s):  
Young Adults ◽  
Pilot Study ◽  
Energy Expenditure ◽  
Activities Of Daily Living ◽  
Daily Living

ENERGY EXPENDITURE DURING FIVE ACTIVITIES OF DAILY LIVING IN HEALTHY YOUNG ADULTS.

2008 ◽  
Vol 19 (4) ◽  
pp. 133
Author(s):  
Jacqueline S Drouin ◽  
Virginia Stevens ◽  
Karma Stuart ◽  
Laura Baker
Keyword(s):  
Young Adults ◽  
Energy Expenditure ◽  
Activities Of Daily Living ◽  
Daily Living

Non-invasive monitoring of the activities of daily living of elderly people at home – a pilot study of the usage of domestic appliances

2008 ◽  
Vol 14 (5) ◽  
pp. 231-235 ◽  
Author(s):  
Georgina Corte Franco ◽  
Floriane Gallay ◽  
Marc Berenguer ◽  
Christine Mourrain ◽  
Pascal Couturier
Keyword(s):  
Pilot Study ◽  
Activities Of Daily Living ◽  
Elderly People ◽  
Daily Living ◽  
Invasive Monitoring ◽  
Non Invasive ◽  
Domestic Appliances ◽  
At Home

A pilot study of dehydroepiandrosterone sulfate in myotonic dystrophy

Neurology ◽  
1998 ◽  
Vol 51 (2) ◽  
pp. 586-589 ◽  
Author(s):  
M. Sugino ◽  
N. Ohsawa ◽  
T. Ito ◽  
S. Ishida ◽  
H. Yamasaki ◽  
...  
Keyword(s):  
Pilot Study ◽  
Muscle Strength ◽  
Activities Of Daily Living ◽  
Myotonic Dystrophy ◽  
Daily Living ◽  
Cardiac Involvement ◽  
Conduction Block ◽  
Dehydroepiandrosterone Sulfate ◽  
Controlled Study ◽  
Premature Beats

We studied the effect of IV administration of a dehydroepiandrosterone sulfate (DHEAS) preparation (200 mg/day for 8 weeks) in 11 patients with myotonic dystrophy (MyD). After DHEAS, activities of daily living improved, muscle strength increased, and myotonia decreased. Conduction block and premature beats also improved in the four patients with cardiac involvement. This pilot study may provide a rationale for a controlled study of DHEAS in MyD.

Symptomatic Treatment in Multiple Sclerosis

US Neurology ◽  
2013 ◽  
Vol 09 (01) ◽  
pp. 35
Author(s):  
Sandra Bigi ◽  
E Ann Yeh ◽  
◽  
Keyword(s):  
Quality Of Life ◽  
Multiple Sclerosis ◽  
Young Adults ◽  
Sexual Dysfunction ◽  
Activities Of Daily Living ◽  
Daily Living ◽  
Negative Impact ◽  
Treatment Options ◽  
Symptomatic Treatment

Multiple sclerosis (MS) is a progressive and disabling neurodegenerative disease that primarily affects young adults. Despite significant therapeutic advances in the prevention of relapses, individuals with MS experience a variety of symptoms, most notably fatigue, spasticity, depression, gait and balance difficulties, and sexual dysfunction. These symptoms may interfere with activities of daily living and have a negative impact on quality of life. This review discusses treatment options for these symptoms.

Sign in / Sign up

Export Citation Format

Share Document